141 related articles for article (PubMed ID: 9113337)
1. Design, synthesis, and biological activity of anti-angiogenic hypoxic cell radiosensitizer haloacetylcarbamoyl-2-nitroimidazoles.
Hori H; Jin CZ; Kiyono M; Kasai S; Shimamura M; Inayama S
Bioorg Med Chem; 1997 Mar; 5(3):591-9. PubMed ID: 9113337
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis inhibitor TX-1898: syntheses of the enantiomers of sterically diverse haloacetylcarbamoyl-2-nitroimidazole hypoxic cell radiosensitizers.
Jin CZ; Nagasawa H; Shimamura M; Uto Y; Inayama S; Takeuchi Y; Kirk KL; Hori H
Bioorg Med Chem; 2004 Sep; 12(18):4917-27. PubMed ID: 15336271
[TBL] [Abstract][Full Text] [Related]
3. Design of antiangiogenic hypoxic cell radiosensitizers: 2-nitroimidazoles containing a 2-aminomethylene-4-cyclopentene-1,3-dione moiety.
Uto Y; Nagasawa H; Jin CZ; Nakayama S; Tanaka A; Kiyoi S; Nakashima H; Shimamura M; Inayama S; Fujiwara T; Takeuchi Y; Uehara Y; Kirk KL; Nakata E; Hori H
Bioorg Med Chem; 2008 Jun; 16(11):6042-53. PubMed ID: 18474428
[TBL] [Abstract][Full Text] [Related]
4. TX-1877: design, synthesis, and biological activities as a BRM-functional hypoxic cell radiosensitizer.
Kasai S; Nagasawa H; Kuwasaka H; Oshodani T; Nishioka A; Ogawa Y; Yoshida S; Inayama S; Inomata T; Hori H
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):799-802. PubMed ID: 9845099
[TBL] [Abstract][Full Text] [Related]
5. New antimetastatic hypoxic cell radiosensitizers: design, synthesis, and biological activities of 2-nitroimidazole-acetamide, TX-1877, and its analogues.
Kasai S; Nagasawa H; Yamashita M; Masui M; Kuwasaka H; Oshodani T; Uto Y; Inomata T; Oka S; Inayama S; Hori H
Bioorg Med Chem; 2001 Feb; 9(2):453-64. PubMed ID: 11249137
[TBL] [Abstract][Full Text] [Related]
6. Radiosensitizers of hypoxic mammalian cells. 1-(Hydroxyaminoalkyl)-substituted nitroimidazoles.
Ahmed I; Stratford IJ; Jenkins TC
Arzneimittelforschung; 1985; 35(12):1763-8. PubMed ID: 4096727
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and radiosensitizing activities of sugar-hybrid hypoxic cell radiosensitizers.
Nakae T; Uto Y; Tanaka M; Shibata H; Nakata E; Tominaga M; Maezawa H; Hashimoto T; Kirk KL; Nagasawa H; Hori H
Bioorg Med Chem; 2008 Jan; 16(2):675-82. PubMed ID: 18029186
[TBL] [Abstract][Full Text] [Related]
8. A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.
Shimamura M; Nagasawa H; Ashino H; Yamamoto Y; Hazato T; Uto Y; Hori H; Inayama S
Br J Cancer; 2003 Jan; 88(2):307-13. PubMed ID: 12610518
[TBL] [Abstract][Full Text] [Related]
9. Correlation Between Radiosensitizing Activity and the Stereo-structure of the TX-2036 Series of Molecules.
Ohkura K; Tabata A; Uto Y; Hori H
Anticancer Res; 2019 Aug; 39(8):4479-4483. PubMed ID: 31366548
[TBL] [Abstract][Full Text] [Related]
10. Effect of molecular chirality and side chain bulkiness on angiogenesis of haloacetylcarbamoyl-2-nitroimidazole compounds.
Ohkura K; Uto Y; Nagasawa H; Hori H
Anticancer Res; 2007; 27(6A):3693-700. PubMed ID: 17970030
[TBL] [Abstract][Full Text] [Related]
11. Comparison of hypoxic cell radiosensitizers, KIN-804, KIN-844, KIN-806 and TX-1877, on brain and liver metabolizing capacities in mice bearing Ehrlich ascites carcinoma.
Abou-Bedair FA; Hori H; Nagasawa H; Uto Y; Abu-Zeid M; Inayama S
Biol Pharm Bull; 2002 May; 25(5):591-6. PubMed ID: 12033498
[TBL] [Abstract][Full Text] [Related]
12. Chloronitroimidazoles as radiosensitizers of hypoxic cells in vitro.
Wideł M; Watras J; Suwiński J; Salwińska E
Neoplasma; 1987; 34(3):241-51. PubMed ID: 3614460
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-selective antitumor agents. 8. Bis(nitroimidazolyl)alkanecarboxamides: a new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitisers.
Hay MP; Wilson WR; Moselen JW; Palmer BD; Denny WA
J Med Chem; 1994 Feb; 37(3):381-91. PubMed ID: 8308864
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of potential dual-acting radiation sensitizer antineoplastic agents: 2,2-dimethylphosphoraziridines containing 2-nitroimidazoles or other electron-affinic moieties.
Perlman ME; Dunn JA; Piscitelli TA; Earle J; Rose WC; Wampler GL; MacDiarmid JE; Bardos TJ
J Med Chem; 1991 Apr; 34(4):1400-7. PubMed ID: 2016716
[TBL] [Abstract][Full Text] [Related]
15. In vivo radiosensitizing effect of nitroimidazole derivative KIN-804.
Tada T; Nakajima T; Onoyama Y; Murayama C; Mori T; Nagasawa H; Hori H; Inayama S
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):601-5. PubMed ID: 8005823
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of antiangiogenic/heparin-binding arginine dendrimer mimicking the surface of endostatin.
Kasai S; Nagasawa H; Shimamura M; Uto Y; Hori H
Bioorg Med Chem Lett; 2002 Mar; 12(6):951-4. PubMed ID: 11959001
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological activities of antiangiogenic hypoxic cytotoxin, triazine-N-oxide derivatives.
Nagasawa H; Yamashita M; Mikamo N; Shimamura M; Oka S; Uto Y; Hori H
Comp Biochem Physiol A Mol Integr Physiol; 2002 May; 132(1):33-40. PubMed ID: 12062188
[TBL] [Abstract][Full Text] [Related]
18. Potential radiosensitizing agents. 7. 4(5)-Iodo-5(4)-nitroimidazole derivatives.
Gupta RP; Larroquette CA; Agrawal KC; Grodkowski J; Neta P
J Med Chem; 1985 Aug; 28(8):987-91. PubMed ID: 4020837
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of the enantiomers of the bioreductively-activated cytotoxin RSU-1069 and its prodrug RB6145 and lack of stereoselectivity in their cytotoxicity and radiosensitization in vitro.
Naylor MA; Threadgill MD; Showalter HD; Stratford IJ; Stephens MA; Fielden EM; Adams GE
Drug Des Discov; 1993; 10(3):249-55. PubMed ID: 8268395
[TBL] [Abstract][Full Text] [Related]
20. The novel hypoxic cell radiosensitizer, TX-1877 has antitumor activity through suppression of angiogenesis and inhibits liver metastasis on xenograft model of pancreatic cancer.
Miyake K; Shimada M; Nishioka M; Sugimoto K; Batmunkh E; Uto Y; Nagasawa H; Hori H
Cancer Lett; 2008 Dec; 272(2):325-35. PubMed ID: 18762366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
